Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nanoliposomal Irinotecan”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Testing effectiveness (Phase 2)UnknownNCT04617457
What this trial is testing

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerMetastasisSurgery+1 more
University of Cologne 150
Not applicableStudy completedNCT04984174
What this trial is testing

Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan

Who this might be right for
Pancreatic Cancer
National Cancer Center, Korea 14,760
Large-scale testing (Phase 3)Study completedNCT05074589
What this trial is testing

Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Who this might be right for
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
Jiangsu HengRui Medicine Co., Ltd. 298
Not applicableLooking for participantsNCT07340151
What this trial is testing

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Pancreas
The University of Texas Health Science Center at San Antonio 40
Testing effectiveness (Phase 2)Ended earlyNCT05009953
What this trial is testing

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+1 more
CSPC Ouyi Pharmaceutical Co., Ltd. 17
Testing effectiveness (Phase 2)Looking for participantsNCT06023641
What this trial is testing

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Who this might be right for
Rhabdomyosarcoma
St. Jude Children's Research Hospital 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07239622
What this trial is testing

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian CancerOvarian Clear Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07208539
What this trial is testing

AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Shanghai Zhongshan Hospital 77
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04901741
What this trial is testing

Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
TME Pharma AG 60
Testing effectiveness (Phase 2)Looking for participantsNCT07047560
What this trial is testing

Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study

Who this might be right for
Colorectal Cancer (CRC)
Tianjin Medical University Cancer Institute and Hospital 46
Early research (Phase 1)Not Yet RecruitingNCT07782346
What this trial is testing

Liposomal Irinotecan Plus Cisplatin in Patients With Advanced or Metastatic Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
National Health Research Institutes, Taiwan 44
Large-scale testing (Phase 3)Study completedNCT03088813
What this trial is testing

Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ipsen 491
Testing effectiveness (Phase 2)UnknownNCT06437678
What this trial is testing

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06531278
What this trial is testing

Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

Who this might be right for
Pancreatic Cancer Metastatic to Liver
Jiang Long 40
Testing effectiveness (Phase 2)Study completedNCT06478043
What this trial is testing

Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC

Who this might be right for
Small-cell Lung Cancer
Zhejiang Cancer Hospital 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT06501664
What this trial is testing

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Who this might be right for
Esophageal Cancer
Rui-hua Xu, MD, PhD 360
Not applicableUnknownNCT06282120
What this trial is testing

Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer

Who this might be right for
Metastatic Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570914
What this trial is testing

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)Colorectal CancerLiver Metastasis
Tianjin Medical University Cancer Institute and Hospital 28
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Testing effectiveness (Phase 2)Study completedNCT04009876
What this trial is testing

Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Fundación de investigación HM 30
Next Page